Cargando…

Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment

The US Preventive Services Task Force recommends lung cancer screening (LCS) to promote early lung cancer detection, and tobacco cessation services are strongly recommended in adjunct. Screen ASSIST (NCT03611881) is a randomized factorial trial to ascertain the best tobacco treatment intervention fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Elyse R, Neil, Jordan M, Noonan, Elise, Howard, Sydney E, Gonzalez, Irina, Marotta, Caylin, Wint, Amy J, Levy, Douglas E, Chang, Yuchiao, Rigotti, Nancy A, Haas, Jennifer S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653214/
https://www.ncbi.nlm.nih.gov/pubmed/36350049
http://dx.doi.org/10.1093/jncics/pkac073
_version_ 1784828637066821632
author Park, Elyse R
Neil, Jordan M
Noonan, Elise
Howard, Sydney E
Gonzalez, Irina
Marotta, Caylin
Wint, Amy J
Levy, Douglas E
Chang, Yuchiao
Rigotti, Nancy A
Haas, Jennifer S
author_facet Park, Elyse R
Neil, Jordan M
Noonan, Elise
Howard, Sydney E
Gonzalez, Irina
Marotta, Caylin
Wint, Amy J
Levy, Douglas E
Chang, Yuchiao
Rigotti, Nancy A
Haas, Jennifer S
author_sort Park, Elyse R
collection PubMed
description The US Preventive Services Task Force recommends lung cancer screening (LCS) to promote early lung cancer detection, and tobacco cessation services are strongly recommended in adjunct. Screen ASSIST (NCT03611881) is a randomized factorial trial to ascertain the best tobacco treatment intervention for smokers undergoing LCS; trial outreach is conducted during 3 recruitment points (RPs): when LCS is ordered (RP1), at screening (RP2), and following results (RP3). Among 177 enrollees enrolled from April 2019 to March 2020, 31.6% enrolled at RP1, 13.0% at RP2, and 55.4% at RP3. The average number of enrollees (per 1000 recruitment days) was 2.26 in RP1, 3.37 in RP2, and 1.04 in RP3. LCS provides an opportunity to offer tobacco treatment at multiple clinical timepoints. Repeated and proactive outreach throughout the LCS experience was beneficial to enrolling patients in tobacco cessation services.
format Online
Article
Text
id pubmed-9653214
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96532142022-11-14 Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment Park, Elyse R Neil, Jordan M Noonan, Elise Howard, Sydney E Gonzalez, Irina Marotta, Caylin Wint, Amy J Levy, Douglas E Chang, Yuchiao Rigotti, Nancy A Haas, Jennifer S JNCI Cancer Spectr Brief Communications The US Preventive Services Task Force recommends lung cancer screening (LCS) to promote early lung cancer detection, and tobacco cessation services are strongly recommended in adjunct. Screen ASSIST (NCT03611881) is a randomized factorial trial to ascertain the best tobacco treatment intervention for smokers undergoing LCS; trial outreach is conducted during 3 recruitment points (RPs): when LCS is ordered (RP1), at screening (RP2), and following results (RP3). Among 177 enrollees enrolled from April 2019 to March 2020, 31.6% enrolled at RP1, 13.0% at RP2, and 55.4% at RP3. The average number of enrollees (per 1000 recruitment days) was 2.26 in RP1, 3.37 in RP2, and 1.04 in RP3. LCS provides an opportunity to offer tobacco treatment at multiple clinical timepoints. Repeated and proactive outreach throughout the LCS experience was beneficial to enrolling patients in tobacco cessation services. Oxford University Press 2022-11-09 /pmc/articles/PMC9653214/ /pubmed/36350049 http://dx.doi.org/10.1093/jncics/pkac073 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Communications
Park, Elyse R
Neil, Jordan M
Noonan, Elise
Howard, Sydney E
Gonzalez, Irina
Marotta, Caylin
Wint, Amy J
Levy, Douglas E
Chang, Yuchiao
Rigotti, Nancy A
Haas, Jennifer S
Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment
title Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment
title_full Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment
title_fullStr Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment
title_full_unstemmed Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment
title_short Leveraging the Clinical Timepoints in Lung Cancer Screening to Engage Individuals in Tobacco Treatment
title_sort leveraging the clinical timepoints in lung cancer screening to engage individuals in tobacco treatment
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653214/
https://www.ncbi.nlm.nih.gov/pubmed/36350049
http://dx.doi.org/10.1093/jncics/pkac073
work_keys_str_mv AT parkelyser leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment
AT neiljordanm leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment
AT noonanelise leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment
AT howardsydneye leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment
AT gonzalezirina leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment
AT marottacaylin leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment
AT wintamyj leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment
AT levydouglase leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment
AT changyuchiao leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment
AT rigottinancya leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment
AT haasjennifers leveragingtheclinicaltimepointsinlungcancerscreeningtoengageindividualsintobaccotreatment